High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-17
DOI
10.3389/fimmu.2018.00724
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
- (2018) Virginia Di Paolo et al. BMC CANCER
- Endothelial cell markers from clinician's perspective
- (2017) Jelena Rakocevic et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- IDO1: An important immunotherapy target in cancer treatment
- (2017) Fangxuan Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Long Non-Coding RNA MALAT1 Promotes Proliferation, Angiogenesis, and Immunosuppressive Properties of Mesenchymal Stem Cells by Inducing VEGF and IDO
- (2017) Xiujun Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Microvessel density as a prognostic factor in esophageal squamous cell cancer patients
- (2017) Guangzhi Ma et al. MEDICINE
- The role of microvessel density, lymph node metastasis, and tumor size as prognostic factors of distant metastasis in colorectal cancer
- (2017) Tomonari Cho et al. Oncology Letters
- Epacadostat Shows Value in Two SCCHN Trials
- (2017) Cancer Discovery
- Strategies targeting angiogenesis in advanced non-small cell lung cancer
- (2017) Jun Wang et al. Oncotarget
- Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma
- (2016) Ahlem Ben-Haj-Ayed et al. IMMUNOLOGY LETTERS
- Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma
- (2016) Hao Liu et al. Scientific Reports
- Targeting the indoleamine 2,3-dioxygenase pathway in cancer
- (2015) Yong Wha Moon et al. Journal for ImmunoTherapy of Cancer
- Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation
- (2014) Luciana Cavalheiro Marti et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas
- (2013) I S Haldorsen et al. BRITISH JOURNAL OF CANCER
- Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry
- (2013) Hatem Soliman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
- (2012) Courtney Smith et al. Cancer Discovery
- Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T CellsIn Situand Lymph Node Metastasis
- (2011) Jinpu Yu et al. Clinical & Developmental Immunology
- High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma
- (2011) Jocelyne Jacquemier et al. INTERNATIONAL JOURNAL OF CANCER
- Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells
- (2011) Jingyan Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion
- (2010) Saga INTERNATIONAL JOURNAL OF ONCOLOGY
- Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
- (2008) Ke Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started